US8945642B2 - Nutritionally enhanced isolate from stabilized rice bran and method of production - Google Patents
Nutritionally enhanced isolate from stabilized rice bran and method of production Download PDFInfo
- Publication number
- US8945642B2 US8945642B2 US12/882,202 US88220210A US8945642B2 US 8945642 B2 US8945642 B2 US 8945642B2 US 88220210 A US88220210 A US 88220210A US 8945642 B2 US8945642 B2 US 8945642B2
- Authority
- US
- United States
- Prior art keywords
- slurry
- rice bran
- protease
- stabilized rice
- range
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 238000000034 method Methods 0.000 title claims abstract description 32
- 235000007164 Oryza sativa Nutrition 0.000 title claims description 15
- 235000009566 rice Nutrition 0.000 title claims description 15
- 238000004519 manufacturing process Methods 0.000 title description 4
- 240000007594 Oryza sativa Species 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 claims abstract description 71
- 108090000790 Enzymes Proteins 0.000 claims abstract description 71
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 28
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 28
- 229940088598 enzyme Drugs 0.000 claims description 65
- 239000002002 slurry Substances 0.000 claims description 57
- 235000018102 proteins Nutrition 0.000 claims description 27
- 239000000463 material Substances 0.000 claims description 19
- 239000000835 fiber Substances 0.000 claims description 18
- 108091005804 Peptidases Proteins 0.000 claims description 17
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 16
- 101710130006 Beta-glucanase Proteins 0.000 claims description 14
- 229920001353 Dextrin Polymers 0.000 claims description 14
- 239000004375 Dextrin Substances 0.000 claims description 14
- 241000209094 Oryza Species 0.000 claims description 14
- 235000019425 dextrin Nutrition 0.000 claims description 14
- 238000010438 heat treatment Methods 0.000 claims description 14
- 229920002472 Starch Polymers 0.000 claims description 13
- 230000008569 process Effects 0.000 claims description 13
- 235000019698 starch Nutrition 0.000 claims description 13
- 239000008107 starch Substances 0.000 claims description 13
- 239000004365 Protease Substances 0.000 claims description 10
- 102000004139 alpha-Amylases Human genes 0.000 claims description 10
- 108090000637 alpha-Amylases Proteins 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 235000019419 proteases Nutrition 0.000 claims description 7
- 235000009467 Carica papaya Nutrition 0.000 claims description 5
- 240000006432 Carica papaya Species 0.000 claims description 3
- 235000004252 protein component Nutrition 0.000 claims description 3
- 108090000526 Papain Proteins 0.000 claims 4
- 241000219173 Carica Species 0.000 claims 2
- 108090001069 Chymopapain Proteins 0.000 claims 2
- 108010092515 glycyl endopeptidase Proteins 0.000 claims 2
- 229940055729 papain Drugs 0.000 claims 2
- 235000019834 papain Nutrition 0.000 claims 2
- 235000016709 nutrition Nutrition 0.000 abstract description 15
- 239000003963 antioxidant agent Substances 0.000 abstract description 10
- 230000003078 antioxidant effect Effects 0.000 abstract description 6
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000003925 fat Substances 0.000 description 17
- 235000019197 fats Nutrition 0.000 description 17
- 239000004382 Amylase Substances 0.000 description 10
- 108010065511 Amylases Proteins 0.000 description 9
- 102000013142 Amylases Human genes 0.000 description 9
- 235000019418 amylase Nutrition 0.000 description 9
- 235000006708 antioxidants Nutrition 0.000 description 9
- 239000007787 solid Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 239000012223 aqueous fraction Substances 0.000 description 6
- 239000011942 biocatalyst Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 201000001320 Atherosclerosis Diseases 0.000 description 4
- 208000035150 Hypercholesterolemia Diseases 0.000 description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- 230000006978 adaptation Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002417 nutraceutical Substances 0.000 description 3
- 235000021436 nutraceutical agent Nutrition 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000011785 micronutrient Substances 0.000 description 2
- 235000013369 micronutrients Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 229920002245 Dextrose equivalent Polymers 0.000 description 1
- 108010001817 Endo-1,4-beta Xylanases Proteins 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 241001557886 Trichoderma sp. Species 0.000 description 1
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 208000018937 joint inflammation Diseases 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000009120 supportive therapy Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A23L1/1016—
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/115—Cereal fibre products, e.g. bran, husk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
-
- A23L1/095—
-
- A23L1/1055—
-
- A23L1/3002—
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
- A23L7/107—Addition or treatment with enzymes not combined with fermentation with microorganisms
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/02—Pretreatment
- C11B1/025—Pretreatment by enzymes or microorganisms, living or dead
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to a process of producing a nutritionally enhanced derivative (isolate) from Stabilized Rice Bran (SRB) with improved yield characteristics.
- Rice bran is a nutrient-dense composition derived from the milling of rice.
- Rice bran is a rich source of protein, fat, carbohydrate and a number of micronutrients such as vitamins, minerals, anti-oxidants and phytosterols.
- rice bran To be useful as a food ingredient, rice bran must be stabilized. That is, the lipid hydrolyzing and oxidizing enzymes present in the bran must be inactivated in order to prevent interaction of those enzymes, lipase and peroxidase in particular, with the oil fraction. If these enzymes are not inactivated, hydrolytic and oxidative rancidity will proceed, causing the formation of objectionable odors and flavors commonly associated with rancidity.
- rice bran serves as a dietary nutrient useful in a variety of food and beverage formulations.
- SRB Stabilized Rice Bran
- the nutrients in SRB are preferably extracted into a concentrated isolate for use in commercial food and beverage formulations.
- existing processes for the production of SRB derivatives provide inefficient yields and limited nutritional profiles compared to the potential available in SRB.
- the enzyme alpha-amylase has been used to treat an aqueous slurry of SRB to convert the starch component of the SRB into a dextrin slurry that can be isolated by centrifugation and subsequent drying.
- the resulting dextrin product typically represents only forty to fifty percent of the starting weight of the SRB, and unlike nutrient-rich SRB, the dextrin product has a limited nutritional profile and is low in protein and antioxidant rich fat content.
- the fat content in SRB has special qualities that can be maximized to enhance the nutraceutical nutritional value of the dextrin isolate.
- the fat/oil component of SRB is dense with numerous antioxidants that provide SRB with an extremely high nutraceutical nutritional capacity.
- the antioxidant capacity of SRB is several magnitudes higher than foods more commonly known to be high in antioxidants. For instance, Xianli Wu et al., in the Journal of Food Composition and Analysis 17 (2004) at pages 407-422 (incorporated herein by reference), listed total antioxidant capacity (hydrophilic and lipophylic ORAC FL ) of 28 selected foods.
- a nutritionally enhanced derivative (isolate) from SRB with improved yield characteristics and method for producing same.
- a nutritionally enhanced isolate of Stabilized Rice Bran is provided, which is prepared by a process comprising the steps of: providing a Stabilized Rice Bran material; adding water to the Stabilized Rice Bran material to produce a slurry including an insoluble fiber fraction; adding a beta-glucanase enzyme to the slurry; heating the slurry sufficiently to activate the beta-glucanase enzyme to release fat components from the insoluble fiber fraction into a soluble fat fraction; and isolating the soluble fat fraction.
- the nutritionally enhanced isolate of Stabilized Rice Bran may then, in certain embodiments, be further prepared by a process further comprising the steps of: adding a protease enzyme to the slurry; heating the slurry sufficiently to activate the protease enzyme to create a soluble protein fraction from the Stabilized Rice Bran material; and isolating the soluble protein fraction.
- the nutritionally enhanced isolate of Stabilized Rice Bran may in certain embodiments be prepared by a process further comprising the steps of: adding an alpha amylase enzyme to the slurry; heating the slurry sufficiently to activate the alpha amylase enzyme to convert starch in the Stabilized Rice Bran material into a soluble dextrin fraction; and isolating the soluble dextrin fraction.
- the nutritionally enhanced isolate of Stabilized Rice Bran may in certain embodiments be prepared by a process further comprising the steps of: heating the slurry to a first temperature for a first time period; and heating the slurry to a second temperature for a second time period.
- the first temperature may be selected from a range of about 50° C. to 110° C., for instance, in certain embodiments from a range of about 57° C. to 97° C.
- the first time period may be no less than about 1 minute and no more than about 120 minutes, for instance, in certain embodiments no less than about 15 minutes and no more than about 45 minutes.
- the second temperature may be selected from a range of about 50° C.
- the second time period may be no less than about 1 minute and no more than about 120 minutes, for instance, in certain embodiments from no less than about 1 minute and no more than about 10 minutes.
- the slurry may in various embodiments have a pH selected from a range of about 3.0 to about 7.5, for instance, in certain embodiments from a range of about 6.0 to about 7.0.
- a nutritionally enhanced isolate of Stabilized Rice Bran is provided, which is prepared by a process comprising the steps of: providing a Stabilized Rice Bran material; adding water to the Stabilized Rice Bran material to produce a slurry; adding a beta-glucanase enzyme to the slurry; heating the slurry sufficiently to activate the beta-glucanase enzyme to create a soluble fiber fraction from the Stabilized Rice Bran material; and isolating the soluble fiber fraction. All of the aforementioned aspects may apply to these embodiments.
- Also provided is a method of creating a nutritionally enhanced isolate of Stabilized Rice Bran comprising the steps of: providing a Stabilized Rice Bran material; adding water to the Stabilized Rice Bran material to produce a slurry; adding a protease enzyme to the slurry; heating the slurry sufficiently to activate the protease enzyme to create a soluble protein fraction from the Stabilized Rice Bran material; and isolating the soluble protein fraction.
- the method may further comprise the steps of: adding a beta-glucanase enzyme to the slurry; heating the slurry sufficiently to activate the beta-glucanase enzyme to create a soluble fiber fraction from the Stabilized Rice Bran material; and isolating the soluble fiber fraction.
- the method may further comprise the steps of: adding an alpha amylase enzyme to the slurry; heating the slurry sufficiently to activate the alpha amylase enzyme to convert starch in the Stabilized Rice Bran material into a soluble dextrin fraction; and isolating the soluble dextrin fraction.
- the enzyme alpha-amylase has been used to convert the starch component of SRB into a dextrin product lacking in protein, fat, and fiber content.
- the present invention overcomes this limitation by utilizing additional enzymes under a range of conditions to convert protein and fiber in the SRB to less complex fractions that can be isolated from insoluble fractions by screening and centrifuging.
- This new process is referred to herein as the Enhanced Enzyme Treatment and includes treating SRB slurries with certain enzymes in single or multiple process steps to facilitate isolation and inclusion of protein and fiber into the dextrin fraction from SRB. With the inclusion of the protein, fat, and fiber fractions, the yield of the finished product is significantly increased in quantity and improved in nutritional quality.
- EET An example Enhanced Enzyme Treatment
- SI Standard Isolate
- NAI Nutritionally Enhanced Isolate
- the Stabilized Rice Bran was obtained from NutraCea, which has a location at 6720 N. Scottsdale Road, Suite 390, Scottsdale, Ariz. 85253.
- NutraCea's SRB is a shelf stable, USDA approved food-grade ingredient obtained from the vitamin rich outer layers of whole rice. Because nutrients contained in the outer layers of rice bran are very delicate, the rice bran is carefully milled and processed to maximize its freshness and retain its wholesomeness. While SRB from NutraCea was used in this example, the invention is not limited to use of that product, and it will be apparent to persons skilled in the art that other suitable SRB products can be used.
- THERMOSTABLE AMYLASE HTL was obtained from BIO-CAT INC., located at 9117 Three Notch Road, Troy, Va. 22974.
- THERMOSTABLE AMYLASE HTL is an endo-amylase derived from a genetically modified strain of Bacillus licheniformis . This product exhibits high heat and low pH stability in starch hydrolysis and does not require additional calcium for operating under industrial liquefaction conditions.
- THERMOSTABLE AMYLASE HTL randomly hydrolyzes alpha-1,4-glucosidic bonds to reduce the viscosity of gelatinized starch and produce soluble dextrins and oligosaccharides. BIO-CAT INC.
- BIO-CAT INC. recommends a temperature range of 105° C. to 110° C. for 5 to 7 minutes for primary liquefaction, and for secondary liquefaction a temperature range of 95° C. for 90 to 120 minutes (wet mill) and 85° C. to 93° C. for 90 to 120 minutes (dry mill).
- THERMOSTABLE AMYLASE HTL is supplied as a brown liquid that is standardized to not less than 17,400 LU/g.
- One Liquefon Unit is the measure of the digestion time required to produce a color change with iodine solution, indicating a definite stage of dextrinizotion of starch substrate under specified conditions.
- the optimum dosage of THERMOSTABLE AMYLASE HTL will vary with differences in substrate, pH, temperature, and processing time. While THERMOSTABLE AMYLASE HTL was used in this example, the invention is not limited to use of that product, and it will be apparent to persons skilled in the art that other suitable enzyme products can be used, including other alpha amylase enzyme products.
- the slurry was then transferred to four fifty-milliliter centrifuge tubes to a starting weight of forty-five grams each.
- the four tubes were then placed in a high-speed centrifuge (International Equipment Company Model CS) and spun at 5,000 revolutions per minute for five minutes.
- the aqueous fraction containing the soluble isolates were decanted from each tube and recorded for weight.
- the aqueous fractions from each tube were then combined and tested for percent solids, percent fat and percent protein to determine baseline data for a Standard Isolate treated according to this Standard Enzyme Treatment. The results for these combined fractions of Standard Isolate are recorded in Table 1 as Sample 1.
- EET Enhanced Enzyme Treatment
- SRB Nutritionally Enhanced Isolate
- EET Enhanced Enzyme Treatment
- One-hundred grams of SRB (described above) was treated with four-hundred grams of water to produce a twenty percent solids slurry in a 1,000 milliliter beaker.
- the pH value of the resulting slurry measured 6.81 at 25° C.
- To the slurry was added one gram of THERMOSTABLE AMYLASE HTL (described above), one gram of protease enzyme and one gram of beta-glucanase.
- the protease enzyme used in this example was PromodTM 144 GL, obtained from Biocatalysts Limited, located at Cefn Coed, Parc Nantgarw, CF15 7QQ, Wales, UK.
- PromodTM 144GL is a food-grade botanical protease with at least five proteases of different specificity, and can be used to modify protein functionality in food systems.
- the biological source of PromodTM 144GL is Carica papaya . It has an Activity rating of 100 Papain TU, and is provided in liquid form. PromodTM 144GL is designed to perform in the pH range 5.0-7.5, and is active at temperatures of 50-70° C. according to Biocatalysts Limited.
- PromodTM 144GL The exact level of application of PromodTM 144GL will depend on the protein substrate and the level of modification required. The degree of hydrolysis resulting from action upon a particular protein or protein system will be influenced by enzyme dose, pH, time and temperature. Trials are recommended to determine exact conditions for desired effect. For different degrees of hydrolysis, Biocatalysts Limited makes the following recommendations: high: 70-100 units/kg; moderate: 40-70 units/kg; and low: 20-50 units/kg based on protein weight. Varying pH, time and temperature can also influence the result. While PromodTM 144GL was used in this example, the invention is not limited to use of that product, and it will be apparent to persons skilled in the art that other suitable enzyme products can be used, including other protease enzyme products.
- the beta-glucanase used in this example was DepolTM 686L, also obtained from Biocatalysts Limited, identified above.
- DepolTM 686L is a food-grade broad-spectrum carbohydrase containing beta-glucanase and xylanase.
- the biological source of DepolTM 686L is Trichoderma sp. It has an Activity rating of 5,000 U/g (beta-glucanase), and is provided in the form of a brown liquid.
- DepolTM 686L is designed to perform in the pH range 3.0-6.5, and is active at temperatures of 50-65° C., according to Biocatalysts Limited.
- the pH value of the slurry after these additions measured 6.55 at 25° C.
- the slurry was then heated to 77° C. for thirty minutes and then raised to 88° C. and held for five minutes.
- the slurry was checked using an iodine test to determine that no starch remained in the slurry.
- Table 3 compares the NEI Totals from Table 2 to the SI Totals from Table 1. As clearly indicated in Table 3, the NEI Totals from the example Enhanced Enzyme Treatment were substantially higher than the SI Totals from the Standard Enzyme Treatment. Accordingly, applying an Enhanced Enzyme Treatment to an SRB isolate substantially increases yield and improves nutritional profile over and above applying Standard Enzyme Treatment. For example, but not by way of limitation, applying the above example Enhanced Enzyme Treatment to an SRB isolate increased decanted weight by 8.9 percent, increased solids by 59.8 percent, and increased dry basis weight by 73.1 percent, over and above applying Standard Enzyme Treatment. And with regard to nutritional profile, applying Enhanced Enzyme Treatment to an SRB isolate increased the yield of fats by 167.6 percent and the yield of proteins by 220.9 percent, over and above applying Standard Enzyme Treatment, as shown below in Table 3:
- one or more different enzymes can be introduced to the slurry in addition to, or instead of, the example enzymes described herein.
- a cellulase enzyme could be used, or any other suitable fiber and/or protein and/or fat-solublizing enzyme(s).
- the type of enzyme(s) and their relative dose(s) can be varied.
- the enzyme(s) can be introduced in a different form or phase at the same or different points in the process, and other variables can be adjusted as will be apparent to persons skilled in the art, including, pH, times, and temperatures.
- pH can be selected in the range from 5.5 to 5.8, while in other embodiments pH can be selected in the range from 5.0 to 7.5, while in yet other embodiments pH can be selected in the range from 3.0 to 6.5, and in still other embodiments pH can be selected in the range from 3.0 to 7.5. In one embodiment the pH is selected in the range 6.0 to 7.0. The invention is not limited to these pH ranges, however, unless specifically claimed. Trials are recommended to determine exact conditions for desired effect.
- the slurry was heated to 77° C. (the first temperature) for thirty minutes (the first time) and then raised to 88° C. (the second temperature) and held for five minutes (the second time).
- the first temperature can be selected in the range from 50° C. to 65° C.
- the first temperature can be selected in the range from 50° C. to 70° C.
- the first temperature can be selected in the range from 105° C. to 110° C.
- the first temperature can be selected in the range from 50° C. to 110° C.
- the first temperature is selected in the range from 57° C.
- the second temperature can be higher than, lower than, or the same as the first temperature. More specifically, in certain embodiments the second temperature can be selected in the range from 50° C. to 65° C., while in other embodiments the second temperature can be selected in the range from 50° C. to 70° C., while in yet other embodiments the second temperature can be selected in the range from 105° C. to 110° C., and in still other embodiments the second temperature can be selected in the range from 50° C. to 110° C. In one embodiment the second temperature is selected in the range from 68° C. to 108° C.
- the first and second times can each be varied in certain embodiments to be longer or shorter in duration than the other time, or the first and second times may have the same duration.
- the first and second times can each be selected in the range from 1 minute to 120 minutes.
- the first time is selected in the range from 15 to 45 minutes, and the second time is selected in the range from 1 to 10 minutes.
- Additional time durations e.g., third, fourth, etc.
- at various temperatures may be added, and/or any appropriate time-temperature curve or other shape may be used.
- the invention is not limited to any of the foregoing time or temperature ranges unless specifically claimed. Trials are recommended to determine exact conditions for desired effect. As understood in the art, references in the claims to isolating the various fractions does not require that all of the available material be isolated.
Abstract
Description
TABLE 1 |
Standard Isolate (SI) From Standard Enzyme Treatment (SET) |
Begin | Decant | % | Dry Basis | % As- | % As-Is | |
Wt. (g) | Wt. (g) | Solids | Weight | Is Fat | Protein | |
Sample 1 | 180 | 96 | 7.36 | 7.06 | 1.08 | 0.73 |
Sample 2 | 180 | 100 | 7.38 | 7.38 | 1.28 | 0.86 |
Sample 3 | 180 | 109 | 6.81 | 7.42 | 0.57 | 0.85 |
Sample 4 | 180 | 110 | 7.01 | 7.92 | 0.80 | 0.86 |
SI Totals/ | 720 | 415 | 7.14 | 7.45 | 0.93 | 0.83 |
Averages: | ||||||
2. Example Enhanced Enzyme Treatment (EET)
TABLE 2 |
Nutritionally Enhanced Isolate (NEI) From |
Enhanced Enzyme Treatment (EET) |
Begin | Decant | % | Dry Basis | % As- | % As-Is | |
Wt. (g) | Wt. (g) | Solids | Weight | Is Fat | Protein | |
Sample 1′ | 180 | 109 | 11.48 | 12.51 | 2.40 | 2.54 |
Sample 2′ | 180 | 113 | 11.65 | 13.16 | 2.43 | 2.55 |
Sample 3′ | 180 | 115 | 11.14 | 12.81 | 2.60 | 2.72 |
Sample 4′ | 180 | 115 | 11.37 | 13.08 | 2.55 | 2.78 |
NEI Totals/ | 720 | 452 | 11.41 | 12.89 | 2.50 | 2.65 |
Averages: | ||||||
TABLE 3 |
Improvement Of Nutritionally Enhanced Isolate (NEI) |
Over Standard Isolate (SI) |
Begin | Decant | % | Dry Basis | % As- | % As-Is | |
Wt. (g) | Wt. (g) | Solids | Weight | Is Fat | Protein | |
NEI Totals/ | 0 | 37 | 4.27 | 5.445 | 1.5625 | 1.8225 |
Averages less | ||||||
SI Totals/ | ||||||
Averages: | ||||||
NEI's % | 0.0% | 8.9% | 59.8% | 73.1% | 167.6% | 220.9% |
Increase | ||||||
Over SI | ||||||
Claims (6)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/882,202 US8945642B2 (en) | 2010-09-15 | 2010-09-15 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
NI201100164A NI201100164A (en) | 2010-09-15 | 2011-08-26 | NUTRITIONALLY ENHANCED ISOLATE OF STABILIZED RICE BRAN AND PRODUCTION METHOD |
US13/494,998 US9192180B2 (en) | 2010-09-15 | 2012-06-13 | Nutritionally enhanced fraction from rice bran and method of lowering insulin resistance using same |
US14/573,688 US10238134B2 (en) | 2010-09-15 | 2014-12-17 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US14/923,666 US20160278417A1 (en) | 2010-09-15 | 2015-10-27 | Nutritionally Enhanced Fraction From Rice Bran And Method of Lowering Insulin Resistance Using Same |
US16/271,425 US11039633B2 (en) | 2010-09-15 | 2019-02-08 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US16/573,561 US11540546B2 (en) | 2010-09-15 | 2019-09-17 | Nutraceuticals for the management of conditions related to type 2 diabetes |
US16/575,366 US11547135B2 (en) | 2010-09-15 | 2019-09-18 | Mitigation of chronic infant malnutrition |
US17/341,967 US11944113B2 (en) | 2010-09-15 | 2021-06-08 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US17/993,224 US20230115385A1 (en) | 2010-09-15 | 2022-11-23 | Nutraceuticals for the management of conditions related to type 2 diabetes |
US18/079,177 US20230165291A1 (en) | 2010-09-15 | 2022-12-12 | Mitigation of chronic infant malnutrition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/882,202 US8945642B2 (en) | 2010-09-15 | 2010-09-15 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/494,998 Continuation-In-Part US9192180B2 (en) | 2010-09-15 | 2012-06-13 | Nutritionally enhanced fraction from rice bran and method of lowering insulin resistance using same |
US14/573,688 Continuation US10238134B2 (en) | 2010-09-15 | 2014-12-17 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
Publications (2)
Publication Number | Publication Date |
---|---|
US20120064191A1 US20120064191A1 (en) | 2012-03-15 |
US8945642B2 true US8945642B2 (en) | 2015-02-03 |
Family
ID=45806940
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/882,202 Active 2030-11-19 US8945642B2 (en) | 2010-09-15 | 2010-09-15 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US14/573,688 Active US10238134B2 (en) | 2010-09-15 | 2014-12-17 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US16/271,425 Active US11039633B2 (en) | 2010-09-15 | 2019-02-08 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US17/341,967 Active 2031-01-12 US11944113B2 (en) | 2010-09-15 | 2021-06-08 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/573,688 Active US10238134B2 (en) | 2010-09-15 | 2014-12-17 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US16/271,425 Active US11039633B2 (en) | 2010-09-15 | 2019-02-08 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US17/341,967 Active 2031-01-12 US11944113B2 (en) | 2010-09-15 | 2021-06-08 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
Country Status (2)
Country | Link |
---|---|
US (4) | US8945642B2 (en) |
NI (1) | NI201100164A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10238134B2 (en) | 2010-09-15 | 2019-03-26 | Qjv, Llc | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US20210260147A1 (en) * | 2020-02-25 | 2021-08-26 | Intermark Partners Strategic Management, Llc | Mitigation of chronic infant malnutrition |
US20220054577A1 (en) * | 2020-08-18 | 2022-02-24 | Intermark Partners Strategic Management, Llc | Maternal breast milk with natural bioactive nutraceutical extracts |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017137255A1 (en) * | 2016-02-11 | 2017-08-17 | Nestec S.A. | Vitamin composition |
KR102395172B1 (en) * | 2019-12-23 | 2022-05-10 | (주) 건우에프피 | Rice peptide complex with antihypertensive and antioxidant activity, and food composition comprising the same |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5985344A (en) | 1997-09-02 | 1999-11-16 | The Ricex Company | Process for obtaining micronutrient enriched rice bran oil |
US6126943A (en) | 1997-09-02 | 2000-10-03 | The Ricex Company | Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis |
US6303586B1 (en) | 1997-08-29 | 2001-10-16 | The Ricex Company | Supportive therapy for diabetes, hyperglycemia and hypoglycemia |
US6902739B2 (en) | 2001-07-23 | 2005-06-07 | Nutracea | Methods for treating joint inflammation, pain, and loss of mobility |
US20080038385A1 (en) | 2006-03-13 | 2008-02-14 | Nutracea | Therapeutic uses of an anti-cancer composition derived from rice bran |
US20090162514A1 (en) | 2007-12-21 | 2009-06-25 | Leo Gingras | Production of pasta using rice bran and rice flour |
US20090191308A1 (en) * | 2008-01-28 | 2009-07-30 | Gingras Leo G | Method of preparing emulsified cereal bran derivatives |
US20090220666A1 (en) | 2008-02-11 | 2009-09-03 | Leo Gingras | Utilization of stabilized bran in high protein products |
WO2009109703A1 (en) * | 2008-03-04 | 2009-09-11 | Polar Glucan Oy | Method of producing a bran product |
US20090285919A1 (en) | 2008-05-18 | 2009-11-19 | Alberte Randall S | Rice Bran Extracts for Inflammation and Methods of Use Thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8945642B2 (en) | 2010-09-15 | 2015-02-03 | Ike E. Lynch | Nutritionally enhanced isolate from stabilized rice bran and method of production |
-
2010
- 2010-09-15 US US12/882,202 patent/US8945642B2/en active Active
-
2011
- 2011-08-26 NI NI201100164A patent/NI201100164A/en unknown
-
2014
- 2014-12-17 US US14/573,688 patent/US10238134B2/en active Active
-
2019
- 2019-02-08 US US16/271,425 patent/US11039633B2/en active Active
-
2021
- 2021-06-08 US US17/341,967 patent/US11944113B2/en active Active
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6303586B1 (en) | 1997-08-29 | 2001-10-16 | The Ricex Company | Supportive therapy for diabetes, hyperglycemia and hypoglycemia |
US5985344A (en) | 1997-09-02 | 1999-11-16 | The Ricex Company | Process for obtaining micronutrient enriched rice bran oil |
US6126943A (en) | 1997-09-02 | 2000-10-03 | The Ricex Company | Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis |
US6350473B1 (en) | 1997-09-02 | 2002-02-26 | The Rice Company | Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis |
US6558714B2 (en) | 1997-09-02 | 2003-05-06 | The Ricex Company | Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis |
US6733799B2 (en) | 1997-09-02 | 2004-05-11 | The Ricex Company | Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis |
US6902739B2 (en) | 2001-07-23 | 2005-06-07 | Nutracea | Methods for treating joint inflammation, pain, and loss of mobility |
US20080038385A1 (en) | 2006-03-13 | 2008-02-14 | Nutracea | Therapeutic uses of an anti-cancer composition derived from rice bran |
US20090162514A1 (en) | 2007-12-21 | 2009-06-25 | Leo Gingras | Production of pasta using rice bran and rice flour |
US20090191308A1 (en) * | 2008-01-28 | 2009-07-30 | Gingras Leo G | Method of preparing emulsified cereal bran derivatives |
US20090220666A1 (en) | 2008-02-11 | 2009-09-03 | Leo Gingras | Utilization of stabilized bran in high protein products |
WO2009109703A1 (en) * | 2008-03-04 | 2009-09-11 | Polar Glucan Oy | Method of producing a bran product |
US20090285919A1 (en) | 2008-05-18 | 2009-11-19 | Alberte Randall S | Rice Bran Extracts for Inflammation and Methods of Use Thereof |
WO2009143065A2 (en) | 2008-05-18 | 2009-11-26 | Rice Science, Llc | Rice bran extracts and methods of use thereof |
WO2009143064A2 (en) | 2008-05-18 | 2009-11-26 | Rice Science, Llc | Rice bran extracts for inflammation and methods of use thereof |
US20100015258A1 (en) | 2008-05-18 | 2010-01-21 | Alberte Randall S | Rice Bran Extracts and Methods of Use Thereof |
Non-Patent Citations (6)
Title |
---|
Hanmoungjai, P. et al. 2002. Enzyme-assisted water-extraction of oil and protein from rice bran. J. Chem. Tech. Biotech. 77:771-776. * |
Lynch, et al, How Does Diabatrol® Work?, White Paper, Jan. 8, 2010, passim. |
Qureshi, A.A. et al, ‘Effects of stabilized rice bran, its soluble and fiber fractions, on blood glucose levels and serum lipid parameters in humans with diabetes mellitus Types I and II’, Journal of Nutritional Biochemistry (2002) 13:175-187. |
Qureshi, A.A. et al, 'Effects of stabilized rice bran, its soluble and fiber fractions, on blood glucose levels and serum lipid parameters in humans with diabetes mellitus Types I and II', Journal of Nutritional Biochemistry (2002) 13:175-187. |
Sharma, A. et al. 2001. Enzyme assisted aqueous extraction of rice bran oil. JAOCS. 78: 949-951. * |
Xianli Wu et al., in the Journal of Food Composition and Analysis 17 (2004) at pp. 407-422 (discussed in background of specification of present application.). |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10238134B2 (en) | 2010-09-15 | 2019-03-26 | Qjv, Llc | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US11039633B2 (en) | 2010-09-15 | 2021-06-22 | Qjv, Llc | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US11944113B2 (en) | 2010-09-15 | 2024-04-02 | Qjv, Llc | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US20210260147A1 (en) * | 2020-02-25 | 2021-08-26 | Intermark Partners Strategic Management, Llc | Mitigation of chronic infant malnutrition |
US20220054577A1 (en) * | 2020-08-18 | 2022-02-24 | Intermark Partners Strategic Management, Llc | Maternal breast milk with natural bioactive nutraceutical extracts |
Also Published As
Publication number | Publication date |
---|---|
US10238134B2 (en) | 2019-03-26 |
US20150104541A1 (en) | 2015-04-16 |
US20210289822A1 (en) | 2021-09-23 |
US20190166891A1 (en) | 2019-06-06 |
NI201100164A (en) | 2012-08-02 |
US11944113B2 (en) | 2024-04-02 |
US20120064191A1 (en) | 2012-03-15 |
US11039633B2 (en) | 2021-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11944113B2 (en) | Nutritionally enhanced isolate from stabilized rice bran and method of production | |
Pineli et al. | Low glycemic index and increased protein content in a novel quinoa milk | |
Wu et al. | Free and bound phenolic profiles of the bran from different rice varieties and their antioxidant activity and inhibitory effects on ɑ-amylose and ɑ-glucosidase | |
Liyanage et al. | Hypolipidemic and hypoglycemic potential of raw, boiled, and sprouted mung beans (Vigna radiata L. Wilczek) in rats | |
Lehmann et al. | Characterization of resistant starch type III from banana (Musa acuminata) | |
Rastmanesh | High polyphenol, low probiotic diet for weight loss because of intestinal microbiota interaction | |
Hübner et al. | Germination of cereal grains as a way to improve the nutritional value: a review | |
Rodriguez-Solana et al. | Carob pulp: A nutritional and functional by-product worldwide spread in the formulation of different food products and beverages. A Review | |
Rosset et al. | Protein extraction from defatted soybean flour with V iscozyme L pretreatment | |
RU2549932C2 (en) | Hydrolysed whole grains containing milk-and-grain beverage for young children | |
de Albuquerque et al. | Potential prebiotic properties of flours from different varieties of sweet potato (Ipomoea batatas L.) roots cultivated in Northeastern Brazil | |
Bamigbade et al. | An updated review on prebiotics: insights on potentials of food seeds waste as source of potential prebiotics | |
Chaiyasut et al. | Assessment of changes in the content of anthocyanins, phenolic acids, and antioxidant property of Saccharomyces cerevisiae mediated fermented black rice bran | |
Marpalle et al. | Nutritional characterization and oxidative stability of α-linolenic acid in bread containing roasted ground flaxseed | |
Powthong et al. | Study of prebiotic properties of selected banana species in Thailand | |
Li et al. | Modulation of gelatinized wheat starch digestion and fermentation profiles by young apple polyphenols in vitro | |
Mbithi-Mwikya et al. | Evaluation of the nutritional characteristics of a finger millet based complementary food | |
RU2536911C1 (en) | Children alimentation products containing hydrolysed whole grains | |
Zhu et al. | Physicochemical properties of steamed bread fortified with ground linseed (Linum usitatissimum) | |
Souza et al. | Antioxidant activity, extraction and application of psyllium mucilage in chocolate drink | |
de Albuquerque et al. | Effects of digested flours from four different sweet potato (Ipomoea batatas L.) root varieties on the composition and metabolic activity of human colonic microbiota in vitro | |
da Silva Dantas et al. | Pilosocereus gounellei (xique-xique) flour: Improving the nutritional, bioactive, and technological properties of probiotic goat-milk yogurt | |
Tian et al. | Effects of banana powder (Musa acuminata Colla) on the composition of human fecal microbiota and metabolic output using in vitro fermentation | |
Klongklaew et al. | Lactic acid bacteria based fermentation strategy to improve phenolic bioactive-linked functional qualities of select chickpea (Cicer arietinum L.) varieties | |
Nikitina et al. | Physico-chemical and antioxidant properties of skimmed varenets (Slavic baked milk yogurt) mixed with enzyme-modified potato starches |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: PETERSON, JOESEPH C, INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:INTERMARK PARTNERS STRATEGIC MANAGEMENT, LLC;REEL/FRAME:036522/0915 Effective date: 20150908 |
|
AS | Assignment |
Owner name: INTERMARK PARTNERS STRATEGIC MANAGEMENT, LLC, INDI Free format text: CORRECTION BY DECLARATION: PREVIOUSLY RECORDED ON REEL 036522/FRAME 0915;ASSIGNOR:INTERMARK PARTNERS STRATEGIC MANAGEMENT, LLC;REEL/FRAME:036885/0979 Effective date: 20151008 |
|
AS | Assignment |
Owner name: INTERMARK PARTNERS STRATEGIC MANAGEMENT, LLC, INDI Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PETERSON, JOSEPH C;REEL/FRAME:040073/0656 Effective date: 20161019 |
|
AS | Assignment |
Owner name: PETERSON, JOSEPH C., INDIANA Free format text: SECURITY INTEREST;ASSIGNOR:INTERMARK PARTNERS STRATEGIC MANAGEMENT, LLC;REEL/FRAME:040634/0394 Effective date: 20160817 |
|
AS | Assignment |
Owner name: INTERMARK PARTNERS STRATEGIC MANAGEMENT, LLC, INDI Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:PETERSON, JOSEPH C;REEL/FRAME:043852/0045 Effective date: 20171011 |
|
AS | Assignment |
Owner name: INTERMARK PARTNERS STRATEGIC MANAGEMENT, LLC, INDI Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LYNCH, IKE E.;SULLIVAN, GLENN H.;MILLER, LARRY R.;SIGNING DATES FROM 20110801 TO 20110804;REEL/FRAME:043907/0279 |
|
AS | Assignment |
Owner name: QJV, LLC, MISSOURI Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:INTERMARK PARTNERS STRATEGIC MANAGEMENT, LLC;REEL/FRAME:044255/0367 Effective date: 20170925 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551) Year of fee payment: 4 |
|
FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FEPP | Fee payment procedure |
Free format text: 7.5 YR SURCHARGE - LATE PMT W/IN 6 MO, SMALL ENTITY (ORIGINAL EVENT CODE: M2555); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 8 |
|
AS | Assignment |
Owner name: NUTRACEUTICAL TECHNOLOGIES INTERNATIONAL LLC, INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:INTERMARK PARTNERS STRATEGIC MANAGEMENT, LLC;REEL/FRAME:066079/0997 Effective date: 20240106 |